Insider · CIK 0001586707
Andrew Hirsch
ceopresidentofficerdirector
Files at EDIT (Editas Medicine, Inc.), CCCC (C4 Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | EDIT Editas Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +37,500 | $0.00 | $0 | 37,500 | Jun 10, 2025 |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | AGrant or award Common Stock | +223,500 | $0.00 | $0 | 445,362 | Feb 18, 2025 |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | FTax withholding Common Stock | -12,847 | $3.18 | $41k | 432,515 | Feb 18, 2025 |
| Feb 15, 2025 | CCCC C4 Therapeutics, Inc. | FTax withholding Common Stock | -9,370 | $3.18 | $30k | 423,145 | Feb 18, 2025 |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +335,300 | $0.00 | $0 | 335,300 | Feb 18, 2025 |
| Nov 7, 2024 | CCCC C4 Therapeutics, Inc. | MOption exercise Common Stock | +12,500 | - | - | 227,412 | Nov 12, 2024 |
| Nov 7, 2024 | CCCC C4 Therapeutics, Inc. | FTax withholding Common Stock | -5,550 | $6.04 | $34k | 221,862 | Nov 12, 2024 |
| Nov 7, 2024 | CCCC C4 Therapeutics, Inc. | MOption exercise Performance Restricted Stock Unitsderivative | -12,500 | $0.00 | $0 | 35,000 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.